Clinical Trials
Overview
Clinical trials are research studies used to find out whether new treatments are safe and effective, and work better than current treatments. Clinical trials are strictly monitored and carefully evaluated.
Trial
Indication
Medicine
TYPE
Description
The SPLASH Study is for men with prostate cancer that has spread beyond the prostate and progressed after hormone therapy. Your doctor will determine whether the SPLASH study may be right for you.
Learn More at the official trial website or NCT04647526 at ClinicalTrials.gov
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER).
Learn more about NCT05432193 at ClinicalTrials.gov
Sponsored by the University Health Network (Toronto, Ontario, Canada), a prospective single arm, multicenter study to evaluate the efficacy and safety of Lutetium-177 Octreotate in patients with neuroendocrine tumors who has positive Somatostatin receptor identified by 68Ga-DOTATATE
Learn more about NCT027437411 at ClinicalTrials.gov